Gilead Asks FDA To Rescind ‘Rare Disease’ Status For Coronavirus Drug Remdesivir : Shots – Health News

After the FDA granted Gilead Sciences orphan drug status for its experimental drug remdesivir Tuesday, Gilead asked that the agency rescind that status Wednesday.
Bloomberg/Bloomberg via Getty Images
In a surprising turnabout, drugmaker Gilead Sciences aske… [+2315 chars]Source